Conference Call will be Friday, April 1st at 10:00am ET / 9:00am CT DALLAS, March 28, 2022--(BUSINESS WIRE)--Blackboxstocks Inc. (NASDAQ: BLBX), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced today announced that the Company will hold… Read More..

Sub-analysis of the Phase 2b CONTROL study in congenital ichthyosis demonstrates treatment success with TMB-001 regardless of subtype BASKING RIDGE, NJ, March 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments… Read More..

Topline data from Phase 2a trial of tegoprubart in ALS expected in 2Q 2022 Ongoing clinical studies evaluating tegoprubart in kidney transplantation, IgA nephropathy, and islet cell transplantation with initial readouts anticipated in late 2022 Cash balance of $84.8M, sufficient to fund operations into 2024 Conference call today at 4:30… Read More..